COMMUNIQUÉS West-GlobeNewswire

Octroi de 1,7 million de dollars en vue du développement de la plateforme ciblée en oncologie de Theratechnologies
04/10/2019
MONTREAL, 04 oct. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que la Société Canadienne du cancer (SCC) et le gouvernement du Québec, par le biais du Consortium [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 30 Septembre 2019
04/10/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 04 oct. 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]
Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2019
04/10/2019
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- [...]
DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy
04/10/2019
Montrouge, France, October 4, 2019 DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy If approved, Viaskin Peanut would be the first and only epicutaneous [...]
DBV Technologies annonce l'acceptation par la FDA du dépôt de sa demande de sa Licence Biologique pour Viaskin Peanut, un traitement de l'allergie aux arachides
04/10/2019
Montrouge, France, le 4 octobre (17 h 30 CEST) 2019 DBV Technologies annonce l'acceptation par la FDA du dépôt de sa demande de sa Licence Biologique pour Viaskin Peanut, un traitement de l'allergie aux arachides Si [...]
Pixium Vision provides clarification on Omnes Capital shareholding, unchanged since end 2017
04/10/2019
Paris, 4 October 2019 – 16:00 CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, [...]
Pixium Vision apporte des précisions sur la participation de Omnes Capital, inchangée depuis fin 2017
04/10/2019
Paris, 4 octobre 2019 – 15:30 CEST - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon [...]
Sarepta Therapeutics Announces Positive Functional Results from the SRP-9003 (MYO-101) Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
04/10/2019
-- Improvements on functional measures seen in all three participants -- -- Significant reduction in creatine kinase maintained over nine months -- -- Results follow positive and robust expression and biomarker data [...]
Conformis Announces Departure of Paul Weiner, CFO
04/10/2019
BILLERICA, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell [...]
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Camelina Platform for Producing PHB Biomaterials to Improve Water Quality at International Scientific Conference
04/10/2019
WOBURN, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Assure Holdings Announces Issuance of Options Under Stock Option Plan
04/10/2019
Company Appoints Scott Kozak as Director of Investor and Media Relations DENVER, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of [...]
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
04/10/2019
NEW YORK, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of patients with rare neurological diseases, [...]
Cynata Advances Toward Phase 2 Clinical Trial of Cymerus(TM) MSCs in Patients with Osteoarthritis
04/10/2019
MELBOURNE, Australia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to provide an update on start-up [...]
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
04/10/2019
SOUTH EASTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based [...]
Optinose Appoints Michael Richardson to New Position of Vice President, Business Development
04/10/2019
YARDLEY, Pa., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported the creation of a new [...]
Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting
04/10/2019
Faster Progressing Patients Who Received Reldesemtiv in the Trial Demonstrated Statistically Significant Differences in the Decline in ALSFRS-R Total Score SOUTH SAN FRANCISCO, Calif., Oct. 04, 2019 (GLOBE NEWSWIRE) -- [...]
Emerald Health Therapeutics’ Joint Venture Pure Sunfarms Begins Shipping Branded Cannabis Product to British Columbia Provincial Wholesaler
04/10/2019
VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced its 50%-owned joint venture for large-scale, low-cost, high-quality [...]
United Health Products Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the HemoStyp® Device for Use in Surgical Procedures
04/10/2019
HENDERSON, Nev., Oct. 04, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC) today announced that it has submitted a Premarket Approval (PMA) application for Class III approval to the FDA for [...]
Fulcrum Therapeutics Announced Results of Phase 1 Clinical Trial of Losmapimod in FSHD
04/10/2019
Data presented in an oral presentation at World Muscle Society meeting highlighted safety, tolerability, pharmacokinetics and target engagement of losmapimod in patients with facioscapulohumeral dystrophy. CAMBRIDGE, [...]

Pages